TRAFEROX — 2178268
Application number
2178268
Type(s)
Standard Characters
Category
Trademark
CIPO Status
ADVERTISED
TM5 status
LIVE/APPLICATION/
Published for Opposition
A pending trademark application has been examined by the Office and has been published in a way that provides an opportunity for the public to oppose its registration.
Filed
2022-04-08
Applicant
Traferox Technologies Inc.
3505 Laird Rd. Unit 16
Mississauga
ONTARIO L5L5Y7
Agent
BORDEN LADNER GERVAIS LLP
Bay Adelaide Centre, East Tower
22 Adelaide St. West
TORONTO
ONTARIO M5H4E3
Documents
Index headings
- TRAFEROX
Goods (Nice class & Statement)
- 5
- (1) Sterile perfusion solutions for medical purposes for use in the preservation of organs, tissues and cells
- 10
- (2) Surgical instruments; medical apparatus, instruments, and disposable medical instruments for the field of organ transplantation, transportation, diagnosis, and ex-vivo organ preservation therapy
Services (Nice class & Statement)
- 39
- (1) Medical services in the field of organ transportation; surgical services for organ transportation
- 40
- (2) Manufacture of surgical instruments and medical apparatus, and disposable medical instruments for the field of organ transplantation, transportation, diagnosis, and ex-vivo organ preservation therapy for others for others
- 42
- (3) Medical research services; scientific research and development in the field of organ transplantation, transportation, diagnosis, and ex-vivo organ preservation therapy; medical and scientific research in the field of organ transplants and ex-vivo therapy; compiling data for research purposes in the field of organ transplants and ex-vivo therapy; research and development in the field of organ transplants and ex-vivo therapy; research and development of new medical and surgical devices for others; providing information about medical and scientific research via a website; software as a service (SAAS) services featuring software for use in medical and scientific research and development in the field of organ transplants and ex-vivo therapy; software as a service (SAAS) services featuring software using artificial intelligence and machine learning for use in the field of organ transplants and ex-vivo therapy; providing online non-downloadable software services for use in medical and scientific research and development in the field of organ transplants and ex-vivo therapy; providing online non-downloadable software using artificial intelligence and machine learning for use in the field of organ transplants and ex-vivo therapy; software development services
- 44
- (4) Medical services in the field of organ transplantation, preservation of organs during transportation, diagnosis, and ex-vivo organ preservation therapy; surgical services for organ transplant, assessment and ex-vivo organ preservation therapy
Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2022-04-08 | ||
| Created | 2022-04-08 | ||
| Formalized | 2022-04-08 | ||
| Pre-Assessment Letter Sent | 2022-05-20 | Retired Goods or Services | |
| Search Recorded | 2025-02-25 | ||
| Examiner's First Report | 2025-02-25 | 2025-08-25 | |
| Agent Changed | 2025-08-22 | From/De: 69 To/A: 6237 | |
| Correspondence Created | 2025-11-06 | 2026-05-06 | |
| Approved | 2026-01-26 | APPROVED BY PROGRAM EX200M1 | |
| Approval Notice Sent | 2026-01-26 | APPROVED BY PROGRAM EX200M1 | |
| Advertised | 2026-04-15 | Vol.73 Issue 3729 |